Vacuum-assisted breast biopsy (VABB) is a minimally invasive procedure and has become an important treatment method. Although VABB is a minimally invasive procedure, it might cause complications, particularly those associated with blood vessels. In this article, we aimed to describe a 35-year-old female who experienced pseudoaneurysm post-VABB and was successfully treated with embolization. She presented to the hospital with a suspected left breast tumor. The pathology report after biopsy confirmed fibroadenoma, and the patient underwent VABB to remove the tumor. One hour after VABB, the patient described pain and swelling at the location of the removed tumor. Breast ultrasound revealed a hematoma and pseudoaneurysm. The bleeding did not stop following the application of manual compression. Breast hemorrhage was controlled by endovascular embolization. Pseudoaneurysm is an uncommon complication of VABB, and embolization represents an effective method for the management of breast pseudoaneurysm.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052620PMC
http://dx.doi.org/10.11604/pamj.2021.38.135.27619DOI Listing

Publication Analysis

Top Keywords

breast pseudoaneurysm
8
vabb minimally
8
minimally invasive
8
invasive procedure
8
breast
6
pseudoaneurysm
5
vabb
5
emergency embolization
4
embolization breast
4
pseudoaneurysm vacuum-assisted
4

Similar Publications

Article Synopsis
  • - A man in his 80s had squamous cell carcinoma on his left temple that was confirmed through biopsy.
  • - After surgery, he faced complications including bleeding, infection, and a pseudoaneurysm of the superficial temporal artery.
  • - Important takeaways involve the recognition and management of uncommon postoperative complications, highlighting that pseudoaneurysms can develop days to weeks after skin cancer surgery.
View Article and Find Full Text PDF
Article Synopsis
  • Abraxane is a common chemotherapy drug used for various cancers, but it has several adverse events (AEs) that need careful monitoring, prompting a study on its safety using data from the FDA Adverse Event Reporting System (FAERS) from 2004 to 2023.
  • Over 10,000 reports of AEs related to Abraxane were analyzed, revealing that blood disorders were the most frequent, with serious outcomes like hospitalization occurring in 36% of cases and deaths in nearly 30%.
  • The study underscores the need for ongoing market surveillance to monitor Abraxane's safety profile and identifies both known and new adverse reactions, highlighting the importance of continuous vigilance in patient
View Article and Find Full Text PDF

Introduction: Breast pseudoaneurysm is a rare complication following breast interventional procedures such as core biopsies and vacuum-assisted biopsies. The occurrence of pseudoaneurysm increases with the conditions of increased breast vascularity like cancer, pregnancy and lactation.

Case Report: We present two cases of pseudoaneurysm formation secondary to core biopsies of the breasts.

View Article and Find Full Text PDF

Pseudoaneurysm in the Axillary Tail of the Breast After A Core Needle Biopsy.

Eur J Breast Health

September 2024

Department of Radiology, University of Miami Miller School of Medicine, Sylvester Cancer Center, and Jackson Memorial Hospital, Florida, USA.

We present the case of a forty-year-old asymptomatic female with no personal or family history of breast cancer, who underwent a core needle biopsy (CNB) following the identification of a focal asymmetry in the right breast on screening mammography. Eight months later, a prominent adjacent vascular structure with a round outpouching was detected on breast ultrasound, confirmed as a post-biopsy pseudoaneurysm. Breast pseudoaneurysms, although exceedingly rare, result from inadvertent vessel puncture during core needle biopsies, particularly when larger gauge needles are used.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!